Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report

Low‐dose interferon‐α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high‐risk polycythemia vera patients.

Detalles Bibliográficos
Autores principales: Driessen, Christoph, Noppen, Christoph, Boonen, Georg, Drewe, Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493450/
https://www.ncbi.nlm.nih.gov/pubmed/34631086
http://dx.doi.org/10.1002/ccr3.4903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493450/
https://www.ncbi.nlm.nih.gov/pubmed/34631086
http://dx.doi.org/10.1002/ccr3.4903

Ejemplares similares